The Jordan Company (Resolute V) Invests in WEP Group Holdings (WEP Clinical)

November 18, 2021

Affiliates of The Resolute Fund V, managed by The Jordan Company, completed an investment in WEP Group Holdings Limited (WEP Clinical), with co-founders Jaswinder and Jaswant Khera remaining significant owners. The capital will support WEP Clinical's organic and inorganic growth as it expands its expanded-access, distribution, pharmacovigilance and market-access services for drug developers worldwide.

Buyers
The Jordan Company, L.P. (via affiliates of The Resolute Fund V, L.P.)
Targets
WEP Group Holdings Limited (WEP Clinical)
Location
United Kingdom
Transaction Type
Growth capital

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.